김대식 교수의 진료시간표

김대식 교수의 상세정보

• 1998 .03  ~  2004 .02  :  고려대학교 의과대학 의학과 졸업, 학사
• 2006 .08  ~  2008 .07  :  고려대학교 대학원 의학과 졸업, 석사
• 2012 .03  ~  2015 .02  :  고려대학교 대학원 의학과 졸업, 박사

• 2004 .03  ~  2005 .02  :  고려대학교 의료원 수련의
• 2005 .03  ~  2009 .02  :  고려대학교 의료원 내과 전공의
• 2009 .04  ~  2012 .04  :  군의관 복무
• 2012 .05  ~  2014 .02  :  고려대학교 구로병원 종양혈액내과 임상강사
• 2014 .03  ~  2016 .08  :  고려대학교 구로병원 종양혈액내과 임상조교수
• 2016 .09  ~   :  고려대학교 구로병원 종양혈액내과 조교수

•  ~   :  대한의사협회, 회원
•  ~   :  대한내과학회, 회원
•  ~   :  대한혈액학회, 회원
•  ~   :  대한혈액학회, 조직구증식증연구회 운영위원
•  ~   :  대한조혈모세포이식학회, 회원
•  ~   :  대한조혈모세포이식학회, 임상시험위원회 운영위원
•  ~   :  대한암학회, 회원
•  ~   :  한국임상암학회, 회원
•  ~   :  대한항암요법연구회, 회원

•  ~  2015  :  Kim DS, Kang KW, Park Y et al, Chemomobilization strategies with intermediate-dose etoposide and delayed use of G-CSF for autologous stem cell transplantation in patients with hematologic malignancies: high effectiveness and delayed platelet recovery. 2015, The 19th Winter Meeting of the Korean Society of Blood and Marrow Transplantation Oral presentation
•  ~  2014  :  Kim DS, Na YJ, Kang MH, et al. Deferasirox, Iron chelator to overcome imatinib resistance in chronic myeloid leukemia cells, 2014, The 55th Autumn Meeting of the Korean Society of Hematology Oral presentation
•  ~  2012  :  Kim DS, Park Y, Choi CW et al. The Results of Chemotherapy for the Elderly Acute Myelogenous Leukemia Patients. 2012, The 53rd Spring Meeting of the Korean Society of Hematology Oral presentation
•  ~  2012  :  Kim DS, Kim JL, Choi CW et at. Inhibition of Hedgehog Pathway in Myeloid Leukemia Cells. 2012, The 53rd Spring Meeting of the Korean Society of Hematology Oral presentation
•  ~  2013  :  Kim DS, Kim JL, Choi CW et at Combination effect of hedgehog inhibitor and iron chelator in myeloid leukemia cells. 2013, The 54th Spring Meeting of the Korean Society of Hematology Oral presentation

•  ~  2017  :  Kim DS, Jung SH, Shin HJ et al. Upfront autologous stem cell transplantation in patients with diffuse large B cell lymphoma: focused on risk factors for survival and conditioning regimen. 2017 The 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation Poster presentation
•  ~   :  Kang KW, Kim DS, Park Y et al. Routine Imaging for Surveillance in Patients with Aggressive Non-Hodgkin Lymphoma in Complete Remission after Frontline Chemotherapy. The 58th American Society of Hematology Annual Meeting and Exposition Poster presentation
•  ~  2015  :  Kim DS, Kang KW, Park Y et al. Chemomobilization strategies with intermediate-dose etoposide and delayed use of G-CSF for autologous stem cell transplantation in patients with hematologic malignancies: high effectiveness and delayed platelet recovery. 2015 The 41st Annual Meeting of the European Society for Blood and Marrow Transplantation Poster presentation
•  ~  2013  :  Kim DS, Kang KW, Park Y et al. High-Dose Cytarabine Consolidation (≥1.5/m2) Might Have Shown a Better Outcomes Than Intermediate-dose Cytarabine (1.0g/m2) Combined With Anthracyclines In AML Patients Who Had Achieved Complete Remissions In The First Induction by Standard 3+7 Regimen. 2013, The 55th American Society of Hematology Annual Meeting and Exposition Poster presentation

• [SCI] (Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib)
• [SCI] (Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma)
• [SCI] (Use of Deferasirox, an Iron Chelator, to Overcome Imatinib Resistance of Chronic Myeloid Leukemia Cells)
• [SCI] (Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas)
• [SCI] (Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines)
• [SCI] (Selection of elderly acute myeloid leukemia patients for intensive chemotherapy: Effectiveness of intensive chemotherapy and subgroup analysis)
• [SCI] (BK virus encephalitis without concurrent hemorrhagic cystitis in an allogeneic hematopoietic stem cell transplant recipient)
• [SCI] (RASSF1A and ERCC1 expression levels might be predictive of prognosis in advanced, recurrent, and metastatic squamous cell carcinoma of the head and neck treated with docetaxel and cisplatin)
• [SCI] (The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease)
• [SCI] (Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis)
• [SCI] (Association of single nucleotide polymorphisms in PIM-1 gene with the risk of Korean lung cancer)
• [SCI] (Clinical factors related to suspected second primary lung cancer development in patients with head and neck cancer)
• [SCI] (The Bone Morphogenesis Protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer)
• [SCI] (Hepatitis B virus reactivation in a surface antigen-negative and antibody-positive patient after rituximab plus CHOP chemotherapy)
• [SCI] (Glucose transporter-1 expression in squamous cell carcinoma of the tongue)

최종수정일 : 2023.05.08